eClinical Solutions LLC Enhances elluminate® Clinical Data Hub Product Offering

MANSFIELD, Mass., Feb. 19, 2019 /PRNewswire-PRWeb/ -- eClinical Solutions LLC, a leading global provider of cloud based products for clinical research and software driven clinical data services, announced an enhanced validation offering, the elluminate Validation Accelerator, is now available for client use. The elluminate Clinical Data Hub is a cloud-based platform used by Life Sciences companies to aggregate, standardize and analyze data from numerous systems and sources across trials providing clinical teams with rapid data insights, improved data quality and reduced cycle time. The elluminate Validation Accelerator provides clients with a risk-based validation approach for elluminate designed to speed the internal quality assurance and validation process.

The comprehensive Validation Accelerator includes a white paper describing the risk-based validation methodology and approach utilized, and how clients can apply it to their specific environment and elluminate implementation. Additionally, it contains a master list of requirements each with an associated risk rating, a quality documentation template library and broad set of test scripts. Clients can use this package according to their internal SOPs to speed internal validation efforts of elluminate, allowing end users to capture greater value from the system quicker.

The market demand is increasing for systems like the elluminate Clinical Data Hub, which provides one source of truth for all clinical data along with intuitive data mapping and comprehensive analytics across data sources. According to Gartner, one of the 2019 LS business priorities is Modernizing Data and Analytic Capabilities for Real-Time Digital Health: Analytics and AI are top areas for increased investment for LS organizations in 2019, according to our 2019 CIO Survey, and are also considered top game-changing technologies. Architecting the right tools, services and skills to (1) deliver data, information and insights, and (2) create analytic literacy is becoming a critical core competency of LS organizations.*

"As the enterprise adoption of elluminate grows, more clients are requesting broader support for a risk-based approach to the internal validation of elluminate and quicker roll-out of new releases." said Raj Indupuri, eClinical Solutions CEO. "We developed this offering in collaboration with clients and clinical system validation experts to make the process of elluminate validation easier and faster for customers."

*Gartner, Business Drivers of Technology Decisions for Life Science Organizations, 2019
Michael Shanler, Jeff Smith, Rich Ross, Mark E. Gilbert, Brad Holmes, 10 January 2019.

SOURCE eClinical Solutions